CRVW Quote, Financials, Valuation and Earnings

DarioHealth Corp. has a net margin of -44.28% compared to CareView Communications, Inc.'s net margin of -41.48%. CareView Communications, Inc.'s return on equity of -- beat DarioHealth Corp.'s return on equity of -41.55%.

CareView Communications, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand DarioHealth Corp. has an analysts' consensus of $18.25 which suggests that it could grow by 73.98%. Given that DarioHealth Corp. has higher upside potential than CareView Communications, Inc., analysts believe DarioHealth Corp. is more attractive than CareView Communications, Inc..

CareView Communications, Inc. has a beta of -0.495, which suggesting that the stock is 149.539% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.077, suggesting its more volatile than the S&P 500 by 7.716%.

CareView Communications, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CareView Communications, Inc. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

CareView Communications, Inc. quarterly revenues are $2.1M, which are smaller than DarioHealth Corp. quarterly revenues of $5M. CareView Communications, Inc.'s net income of -$914.2K is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, CareView Communications, Inc.'s price-to-earnings ratio is -- while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CareView Communications, Inc. is 0.86x versus 5.82x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

GoodRx Holdings, Inc. has a net margin of -44.28% compared to CareView Communications, Inc.'s net margin of 0.57%. CareView Communications, Inc.'s return on equity of -- beat GoodRx Holdings, Inc.'s return on equity of 4.78%.

CareView Communications, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand GoodRx Holdings, Inc. has an analysts' consensus of $4.88 which suggests that it could grow by 81.54%. Given that GoodRx Holdings, Inc. has higher upside potential than CareView Communications, Inc., analysts believe GoodRx Holdings, Inc. is more attractive than CareView Communications, Inc..

CareView Communications, Inc. has a beta of -0.495, which suggesting that the stock is 149.539% less volatile than S&P 500. In comparison GoodRx Holdings, Inc. has a beta of 1.470, suggesting its more volatile than the S&P 500 by 47.004%.

CareView Communications, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GoodRx Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CareView Communications, Inc. pays -- of its earnings as a dividend. GoodRx Holdings, Inc. pays out -- of its earnings as a dividend.

CareView Communications, Inc. quarterly revenues are $2.1M, which are smaller than GoodRx Holdings, Inc. quarterly revenues of $196M. CareView Communications, Inc.'s net income of -$914.2K is lower than GoodRx Holdings, Inc.'s net income of $1.1M. Notably, CareView Communications, Inc.'s price-to-earnings ratio is -- while GoodRx Holdings, Inc.'s PE ratio is 31.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CareView Communications, Inc. is 0.86x versus 1.23x for GoodRx Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

National Research Corp. has a net margin of -44.28% compared to CareView Communications, Inc.'s net margin of 11.54%. CareView Communications, Inc.'s return on equity of -- beat National Research Corp.'s return on equity of 61.55%.

CareView Communications, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that CareView Communications, Inc. has higher upside potential than National Research Corp., analysts believe CareView Communications, Inc. is more attractive than National Research Corp..

CareView Communications, Inc. has a beta of -0.495, which suggesting that the stock is 149.539% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.256%.

CareView Communications, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 2.74% to investors and pays a quarterly dividend of $0.16 per share. CareView Communications, Inc. pays -- of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

CareView Communications, Inc. quarterly revenues are $2.1M, which are smaller than National Research Corp. quarterly revenues of $34.6M. CareView Communications, Inc.'s net income of -$914.2K is lower than National Research Corp.'s net income of $4M. Notably, CareView Communications, Inc.'s price-to-earnings ratio is -- while National Research Corp.'s PE ratio is 26.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CareView Communications, Inc. is 0.86x versus 3.11x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of -44.28% compared to CareView Communications, Inc.'s net margin of 9.46%. CareView Communications, Inc.'s return on equity of -- beat Spok Holdings, Inc.'s return on equity of 10.88%.

CareView Communications, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 60.55%. Given that Spok Holdings, Inc. has higher upside potential than CareView Communications, Inc., analysts believe Spok Holdings, Inc. is more attractive than CareView Communications, Inc..

CareView Communications, Inc. has a beta of -0.495, which suggesting that the stock is 149.539% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.438, suggesting its less volatile than the S&P 500 by 56.19%.

CareView Communications, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.56% to investors and pays a quarterly dividend of $0.31 per share. CareView Communications, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

CareView Communications, Inc. quarterly revenues are $2.1M, which are smaller than Spok Holdings, Inc. quarterly revenues of $33.9M. CareView Communications, Inc.'s net income of -$914.2K is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, CareView Communications, Inc.'s price-to-earnings ratio is -- while Spok Holdings, Inc.'s PE ratio is 16.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CareView Communications, Inc. is 0.86x versus 1.94x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.